International Development News
Development News Edition
Give Feedback

ZAXINE® (rifaximin) - Now Indicated in Canada for Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D)1,2


PTI Montreal
Updated: 07-12-2018 10:36 IST

(Eds: Disclaimer: The following press release comes to you under an arrangement with PR Newswire.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

COUNTRY : India